Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.
Clinical trial NCT02563067 · COMPLETED
Trial details
- NCT number
- NCT02563067
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-03
- Primary completion
- 2019-07-04
- Enrollment
- 877
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.